Efficient cell culture system for hepatitis C virus genotype 6A: Patent #: 8,569,472

Research output: Patent

The present inventors developed hepatitis C virus 6a/2a intergenotypic recombinants in which the JFH1 structural genes (Core, E1 and E2), p7 and the complete NS2 were replaced by the corresponding genes of the genotype 6a reference strain HK6a. Sequence analysis of recovered 6a/2a recombinants from 2 transfection experiments and subsequent reverse genetic studies revealed adaptive mutations in E1 and E2. Conclusion: The developed 6a/2a viruses provide a robust in vitro tool for research in HCV genotype 6, including vaccine studies and functional analysis
Original languageEnglish
IPCC07H 21/00 (20060101); C12N 7/00 (20060101); A61K 39/295 (20060101); A61K 39/12 (20060101); A61K 39/29 (20060101)
Patent numberWO2009/080052
Filing date02/07/2009
Country/TerritoryDenmark
Priority date19/12/2008
Priority numberPCT/DK2008/050332
Publication statusPublished - 29 Oct 2013

ID: 140392838